Resveratrol and P53: How Are They Involved in CRC Plasticity and Apoptosis?

Overview

Journal J Adv Res

Specialties General Medicine
Science

Date 2024 Jan 8

PMID 38190940

Authors

Aranka Brockmueller

Constanze Buhrmann

Amir Reza Moravejolahkami

Mehdi Shakibaei

Affiliations

Soon will be listed here.

Abstract

Background: Colorectal cancer (CRC), which is mainly caused by epigenetic and lifestyle factors, is very often associated with functional plasticity during its development. In addition, the malignant plasticity of CRC cells underscores one of their survival abilities to functionally adapt to specific stresses, including inflammation, that occur during carcinogenesis. This leads to the generation of various subsets of cancer cells with phenotypic diversity and promotes epithelial-mesenchymal transition (EMT), formation of cancer cell stem cells (CSCs) and metabolic reprogramming. This can enhance cancer cell differentiation and facilitate tumorigenic potential, drug resistance and metastasis.

Aim Of Review: The tumor protein p53 acts as one of the central suppressors of carcinogenesis by regulating its target genes, whose proteins are involved in the plasticity of cancer cells, autophagy, cell cycle, apoptosis, DNA repair. The aim of this review is to summarize the latest published research on resveratrol's effect in the prevention of CRC, its regulatory actions, specifically on the p53 pathway, and its treatment options.

Key Scientific Concepts Of Review: Resveratrol, a naturally occurring polyphenol, is a potent inducer of a variety of tumor-controlling. However, the underlying mechanisms linking the p53 signaling pathway to the functional anti-plasticity effect of resveratrol in CRC are still poorly understood. Therefore, this review discusses novel relationships between anti-cellular plasticity/heterogeneity, pro-apoptosis and modulation of tumor protein p53 signaling in CRC oncogenesis, as one of the crucial mechanisms by which resveratrol prevents malignant phenotypic changes leading to cell migration and drug resistance, thus improving the ongoing treatment of CRC.

Citing Articles

Parecoxib Enhances Resveratrol against Human Colorectal Cancer Cells through Akt and TXNDC5 Inhibition and MAPK Regulation.

Chang W, Yang K, Peng J, Hong C, Li P, Chye S Nutrients. 2024; 16(17).

PMID: 39275334 PMC: 11397307. DOI: 10.3390/nu16173020.

Changes in the Expression of Genes Regulating the Response to Hypoxia, Inflammation, Cell Cycle, Apoptosis, and Epithelial Barrier Functioning during Colitis-Associated Colorectal Cancer Depend on Individual Hypoxia Tolerance.

Dzhalilova D, Silina M, Tsvetkov I, Kosyreva A, Zolotova N, Gantsova E Int J Mol Sci. 2024; 25(14).

PMID: 39063041 PMC: 11276979. DOI: 10.3390/ijms25147801.

Innovative Strategies to Combat 5-Fluorouracil Resistance in Colorectal Cancer: The Role of Phytochemicals and Extracellular Vesicles.

Barathan M, Zulpa A, Ng S, Lokanathan Y, Ng M, Law J Int J Mol Sci. 2024; 25(13).

PMID: 39000577 PMC: 11242358. DOI: 10.3390/ijms25137470.

Microbiota and Resveratrol: How Are They Linked to Osteoporosis?.

Meyer C, Brockmueller A, Ruiz de Porras V, Shakibaei M Cells. 2024; 13(13.

PMID: 38994996 PMC: 11240679. DOI: 10.3390/cells13131145.

References

Louis J, McFarland V, May P, Mora P . The phosphoprotein p53 is down-regulated post-transcriptionally during embryogenesis in vertebrates. Biochim Biophys Acta. 1988; 950(3):395-402. DOI: 10.1016/0167-4781(88)90136-4. View

Chin Y, Wei P, Ho Y, Nana A, Changou C, Chen Y . Thyroxine inhibits resveratrol-caused apoptosis by PD-L1 in ovarian cancer cells. Endocr Relat Cancer. 2018; 25(5):533-545. DOI: 10.1530/ERC-17-0376. View

Mohapatra P, Preet R, Choudhuri M, Choudhuri T, Kundu C . 5-fluorouracil increases the chemopreventive potentials of resveratrol through DNA damage and MAPK signaling pathway in human colorectal cancer cells. Oncol Res. 2011; 19(7):311-21. DOI: 10.3727/096504011x13079697132844. View

Piotrowska H, Myszkowski K, Amarowicz R, Murias M, Kulcenty K, Wierzchowski M . Different susceptibility of colon cancer DLD-1 and LOVO cell lines to apoptosis induced by DMU-212, a synthetic resveratrol analogue. Toxicol In Vitro. 2013; 27(8):2127-34. DOI: 10.1016/j.tiv.2013.09.012. View

Gudkov A, Komarova E . p53 and the Carcinogenicity of Chronic Inflammation. Cold Spring Harb Perspect Med. 2016; 6(11). PMC: 5088512. DOI: 10.1101/cshperspect.a026161. View

Heredia A, Davis C, Redfield R . Synergistic inhibition of HIV-1 in activated and resting peripheral blood mononuclear cells, monocyte-derived macrophages, and selected drug-resistant isolates with nucleoside analogues combined with a natural product, resveratrol. J Acquir Immune Defic Syndr. 2000; 25(3):246-55. DOI: 10.1097/00126334-200011010-00006. View

Bando H, Ohtsu A, Yoshino T . Therapeutic landscape and future direction of metastatic colorectal cancer. Nat Rev Gastroenterol Hepatol. 2023; 20(5):306-322. DOI: 10.1038/s41575-022-00736-1. View

Vanamala J, Reddivari L, Radhakrishnan S, Tarver C . Resveratrol suppresses IGF-1 induced human colon cancer cell proliferation and elevates apoptosis via suppression of IGF-1R/Wnt and activation of p53 signaling pathways. BMC Cancer. 2010; 10:238. PMC: 2891636. DOI: 10.1186/1471-2407-10-238. View

Majumdar A, Banerjee S, Nautiyal J, Patel B, Patel V, Du J . Curcumin synergizes with resveratrol to inhibit colon cancer. Nutr Cancer. 2009; 61(4):544-53. PMC: 6370344. DOI: 10.1080/01635580902752262. View

10.

Rodriguez M, Desterro J, Lain S, Lane D, Hay R . Multiple C-terminal lysine residues target p53 for ubiquitin-proteasome-mediated degradation. Mol Cell Biol. 2000; 20(22):8458-67. PMC: 102152. DOI: 10.1128/MCB.20.22.8458-8467.2000. View

11.

Collard T, Guy M, BUTT A, Perks C, Holly J, Paraskeva C . Transcriptional upregulation of the insulin-like growth factor binding protein IGFBP-3 by sodium butyrate increases IGF-independent apoptosis in human colonic adenoma-derived epithelial cells. Carcinogenesis. 2003; 24(3):393-401. DOI: 10.1093/carcin/24.3.393. View

12.

Williams A, Harper S, Paraskeva C . Neoplastic transformation of a human colonic epithelial cell line: in vitro evidence for the adenoma to carcinoma sequence. Cancer Res. 1990; 50(15):4724-30. View

13.

Kim M, Trudel L, Wogan G . Apoptosis induced by capsaicin and resveratrol in colon carcinoma cells requires nitric oxide production and caspase activation. Anticancer Res. 2009; 29(10):3733-40. View

14.

Feng Z . p53 regulation of the IGF-1/AKT/mTOR pathways and the endosomal compartment. Cold Spring Harb Perspect Biol. 2010; 2(2):a001057. PMC: 2828273. DOI: 10.1101/cshperspect.a001057. View

15.

Qin X, Luo H, Deng Y, Yao X, Zhang J, He B . Resveratrol inhibits proliferation and induces apoptosis via the Hippo/YAP pathway in human colon cancer cells. Biochem Biophys Res Commun. 2022; 636(Pt 1):197-204. DOI: 10.1016/j.bbrc.2022.10.077. View

16.

Wang Y, Catana F, Yang Y, Roderick R, van Breemen R . An LC-MS method for analyzing total resveratrol in grape juice, cranberry juice, and in wine. J Agric Food Chem. 2002; 50(3):431-5. DOI: 10.1021/jf010812u. View

17.

Csaki C, Keshishzadeh N, Fischer K, Shakibaei M . Regulation of inflammation signalling by resveratrol in human chondrocytes in vitro. Biochem Pharmacol. 2007; 75(3):677-87. DOI: 10.1016/j.bcp.2007.09.014. View

18.

Brockmueller A, Shayan P, Shakibaei M . Evidence That β1-Integrin Is Required for the Anti-Viability and Anti-Proliferative Effect of Resveratrol in CRC Cells. Int J Mol Sci. 2022; 23(9). PMC: 9099493. DOI: 10.3390/ijms23094714. View

19.

Fang J, Li Z, Li Q, Huang W, Kang L, Wang J . Resveratrol affects protein kinase C activity and promotes apoptosis in human colon carcinoma cells. Asian Pac J Cancer Prev. 2013; 13(12):6017-22. DOI: 10.7314/apjcp.2012.13.12.6017. View

20.

Howitz K, Bitterman K, Cohen H, Lamming D, Lavu S, Wood J . Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature. 2003; 425(6954):191-6. DOI: 10.1038/nature01960. View